162 related articles for article (PubMed ID: 33187360)
1. Design, Synthesis, and In Vitro/In Vivo Anti-Cancer Activities of Novel (20
Dai X; Wu G; Zhang Y; Zhang X; Yin R; Qi X; Li J; Jiang T
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187360
[TBL] [Abstract][Full Text] [Related]
2. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity.
Ling X; Cao S; Cheng Q; Keefe JT; Rustum YM; Li F
PLoS One; 2012; 7(9):e45571. PubMed ID: 23029106
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel 7-substituted 10,11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo.
Zhang G; Yin R; Dai X; Wu G; Qi X; Yu R; Li J; Jiang T
Eur J Med Chem; 2022 Nov; 241():114610. PubMed ID: 35932565
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of FL118 and 9-Q20 cytotoxicity and cellular uptake in 2D and 3D different cell models.
Weng Q; Zhou L; Xia L; Zheng Y; Zhang X; Li F; Li Q
Cancer Chemother Pharmacol; 2019 Sep; 84(3):527-537. PubMed ID: 31030236
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, is highly dependent on its primary structure and steric configuration.
Zhao J; Ling X; Cao S; Liu X; Wan S; Jiang T; Li F
Mol Pharm; 2014 Feb; 11(2):457-67. PubMed ID: 24329001
[TBL] [Abstract][Full Text] [Related]
6. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis.
Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G
Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585
[TBL] [Abstract][Full Text] [Related]
7. FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance.
Westover D; Ling X; Lam H; Welch J; Jin C; Gongora C; Del Rio M; Wani M; Li F
Mol Cancer; 2015 Apr; 14():92. PubMed ID: 25928015
[TBL] [Abstract][Full Text] [Related]
8. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.
Ling X; Wu W; Fan C; Xu C; Liao J; Rich LJ; Huang RY; Repasky EA; Wang X; Li F
J Exp Clin Cancer Res; 2018 Oct; 37(1):240. PubMed ID: 30285798
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 10,11-methylenedioxy-camptothecin glycoside derivatives and investigation of their anti-tumor effects
Wu G; Mai X; Liu F; Lin M; Dong X; Xu Q; Hao C; Zhang L; Yu R; Jiang T
RSC Adv; 2019 Apr; 9(20):11142-11150. PubMed ID: 35520228
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity.
Wang W; Ling X; Wang R; Xiong H; Hu L; Yang Z; Wang H; Zhang Y; Wu W; Singh PK; Wang J; Li F; Li Q
J Med Chem; 2023 Dec; 66(24):16888-16916. PubMed ID: 38100041
[TBL] [Abstract][Full Text] [Related]
11. Pyroptosis is involved in the inhibitory effect of FL118 on growth and metastasis in colorectal cancer.
Tang Z; Ji L; Han M; Xie J; Zhong F; Zhang X; Su Q; Yang Z; Liu Z; Gao H; Jiang G
Life Sci; 2020 Sep; 257():118065. PubMed ID: 32659366
[TBL] [Abstract][Full Text] [Related]
12. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H
Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.
Yar Saglam AS; Kayhan H; Alp E; Onen HI
Mol Biol Rep; 2021 Jan; 48(1):475-489. PubMed ID: 33389483
[TBL] [Abstract][Full Text] [Related]
14. Novel diosgenin-amino acid-benzoic acid mustard trihybrids exert antitumor effects via cell cycle arrest and apoptosis.
Wang W; Li C; Chen Z; Zhang J; Ma L; Tian Y; Ma Y; Guo L; Wang X; Ye J; Wang X
J Steroid Biochem Mol Biol; 2022 Feb; 216():106038. PubMed ID: 34861390
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
Li F; Ling X; Harris DL; Liao J; Wang Y; Westover D; Jiang G; Xu B; Boland PM; Jin C
Am J Cancer Res; 2017; 7(2):370-382. PubMed ID: 28337384
[TBL] [Abstract][Full Text] [Related]
16. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.
Ling X; Xu C; Fan C; Zhong K; Li F; Wang X
Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388
[TBL] [Abstract][Full Text] [Related]
17. A Novel Camptothecin Derivative 3j Inhibits Nsclc Proliferation Via Induction of Cell Cycle Arrest By Topo I-Mediated DNA Damage.
Liu Y; Zhang J; Feng S; Zhao T; Li Z; Wang L; Wang P; Du H; Yuan S; Sun L
Anticancer Agents Med Chem; 2019; 19(3):365-374. PubMed ID: 30523769
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity.
Yang XY; Zhao HY; Lei H; Yuan B; Mao S; Xin M; Zhang SQ
ChemMedChem; 2021 Mar; 16(6):1000-1010. PubMed ID: 33241878
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of 6,7-methylenedioxy-4-substituted phenylquinolin-2(1H)-one derivatives as novel anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase.
Chen YF; Lin YC; Huang PK; Chan HC; Kuo SC; Lee KH; Huang LJ
Bioorg Med Chem; 2013 Sep; 21(17):5064-75. PubMed ID: 23867385
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?
Li F
Am J Cancer Res; 2014; 4(3):304-11. PubMed ID: 24959385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
